期刊文献+

细胞工程在生物制药工业中的地位 被引量:7

The status of cytotechnology in biopharmaceutical industry
下载PDF
导出
摘要 细胞工程是生物制药工业中的关键技术 ,它是利用动物细胞体外培养和扩增来生产生物产品 ,或者作为发现和测试新药的工具。本文综述了细胞工程发展的历史、现状和未来 。 Animal cell technology plays a substantial role in the field of biopharmaceuticals and may be defined as the use of animal cells propagated in vitro for the manufacture of bioproducts and as vehicles in the discovery and/or the testing of medicines. This paper summarized the overview of the past, present and future of animal cell technology, its potential and its limitations in biopharmaceutical industry.
出处 《生物技术通讯》 CAS 2001年第2期117-122,共6页 Letters in Biotechnology
关键词 细胞工程 生物制药 动物细胞培养 animal cell technology, biopharmaceuticals
  • 相关文献

参考文献17

  • 1http://www.fda.gov
  • 2http://www.bio.org
  • 3http://www.actip.org
  • 4Marjan JJ, Allen TM. Long circulating lipsomes: past, present and future. Biotechnology Advances, 1996, 14(2): 151
  • 5Philippot JR, Schuber F. Liposome as tools in basic research and industry. CRC Press, 1995
  • 6Lanza R, Langer R, Chick W. Principles of tissue engineering. R.G. Landes Company, 1997
  • 7Hellstrom I, Hellstrom KE. T cell immunity to tumor antigens, Critical reviews in Immunology, 1998, 18:1
  • 8Walsh G. Biopharmaceuticals: Biochemistry and Biotechnology. John Wiley & Sons, 1998
  • 9Nabel GJ. From rhyme to reason. Nature, 1998, 398(suppl.): 3
  • 10Langer R. Drug delivery and targeting. Nature, 1998, 398(suppl.): 5

二级参考文献34

  • 1cell lines derived from human blastocysts. Science, 1998, 282: 1145
  • 22,Shamblott MJ, Axelman J, Gearhart JD et al. Derivation of pluripotent stem cells fromcultured human primordial germ cells. Proc Natl Acad Sci USA, 1998, 95: 13726
  • 33,KellerG.CurrOpinCellBiol,1995,7:862
  • 44,Nagy A, Rossant J, Nagy R et al. Derivation of completely cell culture-derived micefromm early passage embryonic stem cells. Proc Natl Acad Sci USA,1993, 90: 8424
  • 55,Vogel G. Mice cloned from cultured stem cells. Science,1999,286:2437
  • 66,Wright SJ. Human embryonic stem-cell research: Science and ethic. American Scientist,1999, 97: 352
  • 77,Wilmut I, Schnieke AE, McWhir J et al. Viable offspring derived from fetal and adultmammalian cells. Nature, 1997, 385: 810
  • 88,Marshall E. Claim of human-cow embryo greeted with skepticism. Science, 1998, 282:1390
  • 99,Marshall E. Use of stem cells still legally murky, but hearing offers hope. Science,1998, 282: 1962
  • 1010,Shapiro HT. Ethical dilemmas and stem cell research. Science, 1999, 285: 2065

共引文献25

同被引文献42

  • 1胡显文,陈惠鹏,汤仲明,马清钧.生物制药的现状和未来(一):历史与现实市场[J].中国生物工程杂志,2004,24(12):95-101. 被引量:37
  • 2佚名.中华人民共和国兽用生物制品规程[C].中华人民共和国农业部,2000,45-51.
  • 3R.I.费雷什尼编.实用动物细胞培养液技术[M].-Animal Cell culture,a Proactical approach//潘孝珍等译.北京:世界图书出版公司,1996.
  • 4Thiel K A. Biomanufacturing, from bust to boom ... to bubble?Nature Biotechnology, 2004, 22(11): 1365-1372.
  • 5Morrison S L, Johnson M L, Herzenberg L A, et al. Chimeric human antibody molecules : mouseantigen-binding domains with human constant region domains. Proc Natl Acad Sci USA, 1984,21 : 6851-6855.
  • 6Jones P T,Dear P H,Winter G,et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature, 1986, 321 : 522-525.
  • 7McCafferty J, Griffiths A D, Winter G, et al. Phage antibodies:filamentous phage displaying antibody variable domains. Nature,1990, 348:552-554.
  • 8Green L L. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human moneelonal antibodies. J Immunol Methods,1999, 231:11-23.
  • 9Brekke O H, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nature Reviews Drug Discovery, 2003, 2:52-62.
  • 10Pavlou A,Reichert J.Monoclonal antibodies market.Nature Reviews Drug Discovery, 2004, 3:383 -384.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部